EU Clinical trials Innovation
COG Nordics
ACE Clinical Trials
OCT EU
OCT UK and Ireland
ESC 2025
EADV Congress
ESMO 2025
OCT Nordics
World Orphan Drug Conference
SCOPE EU
COG EU
“I would like to thank you all for the tremendous work done to reach this important milestone for the study in a very challenging and complex global environment. It is the first of many others that we will have to achieve together. Let's keep it up!
Clinical Project Leader, Big Pharma Company
“We are very grateful for your hard work and dedication over the past few years. We are delighted to be part of this partnership and look forward to start treating patients in this new therapeutic area soon. We could not have done this without your contribution. We are very excited about the path ahead and can hardly wait to start this study.
Chief Executive Officer, Biotech Company
“Corporate team and I would like to sincerely thank all the team members, both global and local, as well as the site staff, who have worked extremely hard to reach this lock! This has been achieved under difficult circumstances, being significantly earlier than planned for this discontinued study and in the middle of the COVID-19 pandemic with lockdowns or curfews in place in many of the countries. A huge thank you to all for your team spirit and commitment to reach this goal!
Clinical Project Lead, Big Pharma Company
“Very pleased. Looking forward to getting the country up and running soon.
VP Global Clinical Operations, Medical Device Company
